Diurnal Variation of Maximal Fat Oxidation in metabolic syndrome patients

Circadian Variation of Maximal Fat Oxidation in metabolic syndrome patients

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202306776991260

Enrollment

Registered

2023-06-26

Start date

2023-06-10

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine

Interventions

morning condition

Afternoon condition

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Increased waist circumference (=102 cm in men; =88 cm in women) Elevated triglycerides (=150 mg/dl), or on medication for treating the condition Reduced HDL-cholesterol (<40mg/dl in men, <50 mg/dl in women), or on medication for treating the condition High blood pressure (=130 mmHg systolic or =85mmHg diastolic), or on medication for treating the condition Elevated fasting glucose (=100 mg/dl), or on medication for treating the condition

Exclusion criteria

Exclusion criteria: Any condition that counter-indicate exercise Patients under glucose lowering agents

Design outcomes

Primary

Measure	Time frame
Maximal fat oxidation	—

Secondary

Measure	Time frame
Lipox max ;Heart rate ;Respiratory quotient;VO2 peak;Resting energy expenditure	—

Countries

Tunisia

Contacts

Public ContactJabeur Methnani

Researcher

Jabeur.methnani@gmail.com+21693201456

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026